News

In the oral decision, the District Court dismissed all of the claims filed by MGH except that made under Massachusetts General Law chapter 93A, a consumer protection law

As per the agreement, BioLabs will transfer rights to its pipeline of Curaxin anticancer molecules to the joint venture, and BCV will fund about $15 million in three

The company has signed an agreement to sell its calcium chloride business to a strategic chemical industry buyer for a value in excess of $210m. Employees of the

SOCMA said it is unclear if EPA will use the additional time to reconsider establishing a de minimis threshold. SOCMA had earlier, urged EPA to establish a de

Advaxis’ bioengineered Listeria monocytogenes (Lm) carrier system will be used with Collaborator’s influenza multi-antigen technology to produce oral vaccine against influenza. Thomas A. Moore, CEO of Advaxis, said:

Insight enables healthcare institutions to monitor, measure and analyse over 1000 vital financial and clinical performance indicators. Insight is installed in over 100 hospital facilities. Thomas Mann, President

The phase I trial will be conducted on about 30 to 40 patients suffering from solid tumours and had gone through all the treatments available at present. Following

William Shirey, Executive VP of BDI, said: “The fact that our company’s sales for XYNTHA have tracked twenty-two percent (22%) ahead of the results forecasted for the first

Ernest Egli, President of Roche, Latin America, said: “moksha8 has produced strong results for Roche in Brazil and we are delighted to expand our relationship to include Mexico